öλÔÓéÀֵǼÈë¿ÚÏÂÔØ

ÉúÎﻯѧöλÔÓéÀÖ¹Ù·½appÏÂÔØ¾«½âÃû´Ê½âÊÍ´ð°¸(ÏÂ)°æ(2)

±¾Õ¾Ð¡±à Ãâ·ÑöλÔÓéÀÖ¹Ù·½appÏÂÔØÍø/2019-12-27



12.¸ÔÆéƬ¶Î£¨Okazaki fragment£©£ºÏà¶Ô±È½Ï¶ÌµÄDNAÁ´£¨´óÔ¼1000ºËÜÕËá²Ð»ù£©£¬ÊÇÔÚDNAµÄÖͺóÁ´µÄ²»Á¬ÐøºÏ³ÉÆÚ¼äÉú³ÉµÄƬ¶Î£¬ÕâÊÇReiji OkazakiÔÚDNAºÏ³ÉʵÑéÖÐÌí¼Ó·ÅÉäÐÔµÄÍÑÑõºËÜÕËáǰÌå¹Û²ìµ½µÄ¡£

15.ÍØÆËÒ칹ø£¨Topoisomerase£©£ºÍ¨¹ýÇжÏDNAµÄÒ»Ìõ»òÁ½ÌõÁ´ÖеÄÁ×Ëá¶þõ¥¼ü£¬È»ºóÖØÐ²øÈƺͷâ¿ÚÀ´¸Ä±äDNAÁ¬»·ÊýµÄø¡£ÍØÆËÒ칹ø¢ñ¡¢Í¨¹ýÇжÏDNAÖеÄÒ»ÌõÁ´¼õÉÙ¸º³¬ÂÝÐý£¬Ôö¼ÓÒ»¸öÁ¬»·Êý¡£Ä³Ð©ÍØÆËÒ칹ø¢òÒ²³ÆÎªDNA´ÙÐýø¡£

16.Äæ×ªÂ¼Ã¸£¨Reverse transcriptase£©£ºÒ»ÖÖ´ß»¯ÒÔRNAΪģ°åºÏ³ÉDNAµÄDNA¾ÛºÏø£¬¾ßÓÐRNAÖ¸µ¼µÄDNAºÏ³É¡¢Ë®½âRNAºÍDNAÖ¸µ¼µÄDNAºÏ³ÉµÄø»îÐÔ¡£
13.»¥²¹DNA£¨cDNA£©£ºÍ¨¹ýÄæ×ªÂ¼Ã¸ÒÔmRNAΪģ°åºÏ³ÉµÄË«Á´DNA¡£

17.´íÅäÐÞ¸´£¨Mismatch repair£©£ºÔÚº¬ÓдíÅä¼î»ùµÄDNA·Ö×ÓÖУ¬Ê¹Õý³£ºËÜÕËáÐòÁлָ´µÄÐÞ¸´·½Ê½¡£ÕâÖÖÐÞ¸´·½Ê½µÄ¹ý³ÌÊÇ£ºÊ¶±ð³öÕýÈ·µÄÁ´£¬Çгýµô²»ÕýÈ·Á´µÄ²¿·Ö£¬È»ºóͨ¹ýDNA¾ÛºÏøºÍDNAÁ¬½ÓøµÄ×÷Ó㬺ϳÉÕýÈ·Åä¶ÔµÄË«Á´DNA¡£

18.Ö±½ÓÐÞ¸´£¨Direct repair£©£ºÊÇͨ¹ýÒ»ÖÖ¿ÉÁ¬ÐøÉ¨ÃèDNA£¬Ê¶±ð³öËðÉ˲¿Î»µÄµ°°×ÖÊ£¬½«ËðÉ˲¿Î»Ö±½ÓÐÞ¸´µÄ·½·¨¡£¸ÃÐÞ¸´·½·¨²»ÓÃÇжÏDNA»òÇгý¼î»ù¡£

19.ÇгýÐÞ¸´£¨Excision repair£©£ºÍ¨¹ýÇгý-ÐÞ¸´ÄÚÇÐøʹDNAËðÉËÏû³ýµÄÐÞ¸´·½·¨¡£Ò»°ãÊÇÇгýËðÉËÇø£¬È»ºóÔÚDNA¾ÛºÏøµÄ×÷ÓÃÏ£¬ÒÔ¶³öµÄµ¥Á´ÎªÄ£°åºÏ³ÉÐµĻ¥²¹Á´£¬×îºóÓÃÁ¬½Óø½«È±¿ÚÁ¬½ÓÆðÀ´¡£

µÚÊ®ÁùÕ  RNAµÄºÏ³ÉÓë¼Ó¹¤£¨P198£©

1.²»¶Ô³Æ×ªÂ¼£¨asymmetric transcription£©£ºDNAÁ´ÊÇÓм«ÐԵģ¬RNA¾ÛºÏøÒÔ²»¶Ô³ÆµÄ·½Ê½ÓëÆô¶¯×Ó½áºÏ£¬Ê¹µÃת¼ֻÄÜÑØ×ÅÒ»¸ö·½Ïò½øÐС£¶ÔÒ»¸ö»ùÒò¶øÑÔ£¬»¥²¹Á´ÖÐÖ»ÓÐÒ»ÌõÁ´±»×ªÂ¼³ÉRNA¡£

2.δÒò×Ó£¨δfactor£©£ºÔ­ºËÉúÎïÖÐÓëRNA¾ÛºÏøºËÐÄøÏà½áºÏ¶øÌØÒìÐÔʶ±ðÆô¶¯×ÓÑ¡Ôñת¼ÆðʼµãµÄÒ»¸öµ°°×ÖÊÑÇ»ù¡£

3.Æô¶¯×Ó£¨promoter£©£ºÔÚDNA·Ö×ÓÖУ¬RNA¾ÛºÏøÄܹ»½áºÏ²¢µ¼ÖÂת¼ÆðʼµÄÐòÁС£

8.ºËø£¨ribozyme£©£º¾ßÓÐÏñøÄÇÑù´ß»¯¹¦ÄܵÄRNA·Ö×Ó¡£

9.¶ËÁ£Ã¸£¨telomerase£©£ºÒ»ÖÖ·´×ªÂ¼Ã¸£¬Óɵ°°×ÖʺÍRNAÁ½²¿·Ö×é³ÉºËÌǵ°°×¸´ºÏÌ壬ÆäÖÐRNAÊÇÒ»¶ÎÄ£°åÐòÁУ¬Ö¸µ¼ºÏ³É¶ËÁ£DNAµÄÖØ¸´ÐòÁÐÆ¬¶Î¡£Ò»ÖÖ×ÔÉíЯ´øÄ£°åµÄÄæ×ªÂ¼Ã¸£¬ÓÉRNAºÍµ°°×ÖÊ×é³É£¬RNA×é·ÖÖк¬ÓÐÒ»¶Î¶ÌµÄÄ£°åÐòÁÐÓë¶ËÁ£DNAµÄÖØ¸´ÐòÁл¥²¹£¬¶øÆäµ°°×ÖÊ×é·Ö¾ßÓÐÄæ×ªÂ¼Ã¸»îÐÔ£¬ÒÔRNAΪģ°å´ß»¯¶ËÁ£DNAµÄºÏ³É£¬½«Æä¼Óµ½¶ËÁ£µÄ3′¶Ë£¬ÒÔά³Ö¶ËÁ£³¤¶È¼°¹¦ÄÜ¡£

10.¼ô½Ó£¨splicing£©£º³ýÈ¥²¢Á¬½ÓDNA¡¢RNA»ò¶àëÄÁ´Æ¬¶Î£¬ÐγÉеÄÒÅ´«ÖØ×éÌå»ò¸Ä±äÔ­ÓеÄÒÅ´«½á¹¹µÄ¹ý³Ì¡£

12.ÍâÏÔ×Ó£¨exon£©£º¼È´æÔÚÓÚ×î³õµÄת¼²úÎïÖУ¬Ò²´æÔÚÓÚ³ÉÊìµÄRNA·Ö×ÓÖеĺËÜÕËáÐòÁС£ÊõÓïÍâÏÔ×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÄÚº¬×ÓµÄDNAÖеÄÇøÓò¡£

13.ÄÚº¬×Ó£¨intron£©£ºÔÚת¼ºóµÄ¼Ó¹¤ÖУ¬´Ó×î³õµÄת¼²úÎï³ýÈ¥µÄÄÚ²¿µÄºËÜÕËáÐòÁС£ÊõÓïÄÚº¬×ÓÒ²Ö¸±àÂëÏàÓ¦RNAÍâÏÔ×ÓµÄDNAÖеÄÇøÓò¡£

µÚÊ®ÆßÕ  µ°°×ÖʵĺϳÉÓëתÔË£¨P213£©

1.ÃÜÂë×Ó£¨codon£©£ºmRNA£¨»òDNA£©ÉϵÄÈýÁªÌåºËÜÕËá²Ð»ùÐòÁУ¬¸ÃÐòÁбàÂë×ÅÒ»¸öÖ¸¶¨µÄ°±»ùËá £¬tRNA µÄ·´ÃÜÂë×ÓÓëmRNAµÄÃÜÂë×Ó»¥²¹¡£

2.°±õ£-tRNA£¨aminoacyl-tRNA£©£ºÔÚ°±»ùËá±ÛµÄ3¨@¶ËµÄÏÙÜÕËá²Ð»ù¹²¼ÛÁ¬½ÓÁ˰±»ùËáµÄtRNA·Ö×Ó¡£

3.ºËµ°°×ÌåÑ­»·£¨ribosomal cycle£©£ºÖ¸¶àëÄÁ´ºÏ³É¹ý³ÌÖÐëÄÁ´ÑÓ³¤½×¶Î£¬ËüÓɽøÎ»£¬³ÉëĺÍתλ3¸ö²½ÖèÑ­»·½øÐУ¬Ö±ÖÁÖÕÖ¹½×¶Î¡£

4.¶àºËµ°°×Ì壨polyribosome£©£ºÏ¸°ûÄÚ¶à¸öºËµ°°×ÌåÁ´½ÓÔÚͬһÌõmRNA·Ö×ÓÉÏ£¬½øÐе°°×ÖʺϳÉ¡£ÕâÖÖ¾ÛºÏÌå³ÆÎª¶àºËµ°°×Ìå¡£

16.ëÄõ£×ªÒÆÃ¸£¨peptidyl transferase£©£ºµ°°×ÖÊºÏ³ÉÆÚ¼ä¸ºÔð×ªÒÆëÄõ£»ùºÍ´ß»¯ëļüÐγɵÄø¡£

24.ÆðʼÃÜÂë×Ó£¨initiation factor,IF£©£ºÖ¸¶¨µ°°×ÖÊºÏ³ÉÆðʼλµãµÄÃÜÂë×Ó¡£×î³£¼ûµÄÆðʼÃÜÂë×ÓÊǵ°°±ËáÃÜÂ룺AUG¡£

25.ÖÕÖ¹ÃÜÂë×Ó£¨termination codon£©£ºÈκÎtRNA·Ö×Ó¶¼²»ÄÜÕý³£Ê¶±ðµÄ£¬µ«¿É±»ÌØÊâµÄµ°°×½áºÏ²¢ÒýÆðкϳɵÄëÄÁ´´Ó·­Òë»úÆ÷ÉÏÊͷŵÄÃÜÂë×Ó¡£´æÔÚÈý¸öÖÕÖ¹ÃÜÂë×Ó£ºUAG ,UAAºÍUGA¡£

30.ÃÜÂëµÄ¼ò²¢ÐÔ£¨codon degeneracy£©£ºÊÇָͬһÖÖ°±»ùËá¾ßÓÐÁ½¸ö»ò¸ü¶à¸öÃÜÂë×ÓµÄÏÖÏó¡£


Ïà¹Ø»°Ìâ/ÉúÎﻯѧ

öλÔÓéÀÖ(xinhui)¹Ù·½ÍøÕ¾_öλÔÓéÀÖappÏÂÔØÈë¿Ú